GB202020619D0 - Pharmaceutical Profiler Array for use in Personalised Healthcare - Google Patents
Pharmaceutical Profiler Array for use in Personalised HealthcareInfo
- Publication number
- GB202020619D0 GB202020619D0 GBGB2020619.9A GB202020619A GB202020619D0 GB 202020619 D0 GB202020619 D0 GB 202020619D0 GB 202020619 A GB202020619 A GB 202020619A GB 202020619 D0 GB202020619 D0 GB 202020619D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical
- profiler array
- personalised healthcare
- personalised
- healthcare
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9466—Antidepressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2020619.9A GB202020619D0 (en) | 2020-12-24 | 2020-12-24 | Pharmaceutical Profiler Array for use in Personalised Healthcare |
| EP21843633.5A EP4267962A1 (en) | 2020-12-24 | 2021-12-20 | Pharmaceutical profiler array for use in personalised healthcare |
| PCT/EP2021/086760 WO2022136254A1 (en) | 2020-12-24 | 2021-12-20 | Pharmaceutical profiler array for use in personalised healthcare |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2020619.9A GB202020619D0 (en) | 2020-12-24 | 2020-12-24 | Pharmaceutical Profiler Array for use in Personalised Healthcare |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202020619D0 true GB202020619D0 (en) | 2021-02-10 |
Family
ID=74532081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2020619.9A Ceased GB202020619D0 (en) | 2020-12-24 | 2020-12-24 | Pharmaceutical Profiler Array for use in Personalised Healthcare |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4267962A1 (en) |
| GB (1) | GB202020619D0 (en) |
| WO (1) | WO2022136254A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0874242B2 (en) | 1997-04-21 | 2009-06-03 | Randox Laboratories Ltd. | Device and apparatus for the simultaneous detection of multiple analytes |
| GB201619823D0 (en) | 2016-11-23 | 2017-01-04 | Randox Laboratories Ltd And Teoranta Randox | GFAP accumulating stroke |
| EP3545311B1 (en) | 2016-11-23 | 2024-03-27 | Randox Laboratories Ltd | Gfap derivatives for stroke diagnostics |
-
2020
- 2020-12-24 GB GBGB2020619.9A patent/GB202020619D0/en not_active Ceased
-
2021
- 2021-12-20 EP EP21843633.5A patent/EP4267962A1/en active Pending
- 2021-12-20 WO PCT/EP2021/086760 patent/WO2022136254A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022136254A1 (en) | 2022-06-30 |
| EP4267962A1 (en) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274602A (en) | Pharmaceutical tablets containing altrombophage ulmin, methods for their preparation and use in the preparation of drugs for the treatment of thrombocytopenia | |
| IL202622A (en) | Purine derivatives and pharmaceutical compositions comprising them | |
| DK3117828T3 (en) | CELL PROLIFERATION PROCEDURE AND PHARMACEUTICAL MEDICINE FOR TISSUE REPAIR AND REGENERATION | |
| SI2769729T1 (en) | Polypeptidine and polynucleotides and their uses as the target of medicines for medicinal products and biological medicines | |
| IL216702A0 (en) | Pharmaceutical composition for use in medical and veterinary ophthal mology | |
| GB0803072D0 (en) | Solid pharmaceutical and vaccien dose | |
| BR112015000441A2 (en) | Immunoconjugates, Pharmaceutical Formulation and Treatment Method and Method for Inhibiting Proliferation of a CD22 Positive Cell | |
| ATE538652T1 (en) | SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER | |
| ZA201300920B (en) | Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same | |
| BRPI1005980A2 (en) | therapeutic equipment for treating an individual and computer program product | |
| SI2041129T1 (en) | Human protein-tyrosine phosphatase inhibitors and their pharmaceutical use | |
| BRPI0817396A2 (en) | Method for treating vitamin b12 deficiency in an individual and pharmaceutical composition for treating vitamin b12 deficiency in an individual | |
| DK3479863T3 (en) | COMPOSITIONS, PROCEDURES AND ARTICLES CONTAINING PHARMACEUTICAL NITOXIDE AND REGULATED PATIENT SYSTEMS FOR PATIENTS | |
| IL265970B (en) | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine | |
| BRPI0810816A2 (en) | MEDICINAL PRODUCT AND METHODS FOR TREATING AUTOIMMUNE AND CANCER DISEASES | |
| WO2015079010A3 (en) | Pharmaceutical composition comprising lacosamide and levetiracetam | |
| PT2119453E (en) | PHARMACEUTICAL COMPOSITIONS CAPABLE OF INDUCING APOPTOSIS IN TUMOR CELLS, USEFUL FOR DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC CELL LEUKEMIA | |
| GB202010230D0 (en) | Pharmaceutical formulation | |
| IL207254A0 (en) | Orthopedic plates for use in the midfoot | |
| DK2341900T3 (en) | PHARMACEUTICAL PRODUCT AND TREATMENT | |
| EP2211847A4 (en) | Controlled-release pharmaceutical formulation | |
| IL218008A (en) | Dexanabinol, or a pharmaceutically acceptable salt thereof, for the apoptosis of cancer other than melanoma and use thereof in the manufacture of a medicament for the apoptosis of cancer, other than melanoma and a pharmaceutical composition comprising the same | |
| GB202020619D0 (en) | Pharmaceutical Profiler Array for use in Personalised Healthcare | |
| GB0920721D0 (en) | An orally administered anthelmintic unit dose tablet and process for the preparation thereof | |
| GB202100526D0 (en) | Pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |